All three tenses have at least two readings, so the archetype blend applies as printed.
Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.
What did they actually do?
Has it survived what it has been through?
1 warning event since 2020; the latest 2025-11-07.
From the record
agilon health, inc.'s filings since 2020 show 1 warning event: a notice about its exchange listing (8-K item 3.01, the latest 2025-11-07) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What has it actually done, year after year?
+39.8% a year over 7 filed years; profitable in 0 of 7.
From the record
agilon health, inc.'s 7 filed years say what it did: revenue went from $794 million in fiscal 2019 to $5.9 billion in fiscal 2025, up 39.8% a year; it rose in 5 of 6 years; the deepest fall was 2% from fiscal 2024 to fiscal 2025; net income was positive in 0 of 7 of those years (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How has it treated the people who own it?
SI estimate 5.7/10, confidence 20 of 100 (family median).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: agilon health, inc.'s shareholder treatment is put at 5.7 of 10 with a confidence of 20 of 100, because fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income, so the desk assumes the typical reading of its industry family, the median of 10 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.
What are they doing right now?
Is it financially healthy right now?
ROE -309%: lost 309¢ per shareholder dollar. Leverage 90%: owes 90¢ per asset dollar.
From the record
Return on equity: in the fiscal year ended 2025-12-31, agilon health, inc. lost about 309 cents for every dollar of shareholders' money. Leverage: it owed about 90 cents per dollar of assets (the filed statements).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How strong is its position in its industry?
top 36% of 10 in its family; net margin -6.6%.
From the record
agilon health, inc.'s standing among 10 graded names in its industry family: revenue of $5.9 billion in fiscal 2025 ranks in the top 17% by size; a net margin of -6.6% ranks in the bottom 35%; revenue growth of 35.4% a year over the last 3 filed years ranks in the top 25% (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are the people in charge doing?
bottom 27% of 7 in its family for leadership; chief executive since 2026.
From the record
agilon health, inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is O'Rourke, Timothy Patrick (CEO & President, as filed), filing under that title since 2026-05-11, 6 months (bottom 31% of its family); the 12 officers and directors filing in the last fifteen months have been on the record a median of 4.8 years (bottom 21%); 7 officer or director changes were reported on Form 8-K since 2023-11-13, against the 12 people in charge now (bottom 28%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are they set up to do next?
How much room does it have to grow?
top 45% of 10 in its family for room to expand.
From the record
agilon health, inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $174 million against debt of $16 million leaves 12.4% of its assets as net cash, top 25% of its family; cash from operations less capital spending is -2% of revenue (bottom 35%) (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What could actually drive growth from here?
bottom 35% of 10 in its family for growth drivers.
From the record
agilon health, inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 35.4% a year over the last three filed years against 39.8% over all 7, slowing (bottom 25% of its family); the newest year grew -2.1% (bottom 35%); capital spending grew -5% a year (bottom 45%) (its annual reports). agilon health, inc. reported 2 product lines in fiscal 2025: Medical Services at $5.9 billion (100%), Other Operating at $11 million (0%); 0 of 2 grew against the year before (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Did its newest year beat what its own record pointed to?
bottom 15% of 10 in its family for expectations against reality.
From the record
agilon health, inc.'s newest year against its own record: revenue of $5.9 billion in fiscal 2025 came in 38.5% below the $9.7 billion its prior three years' pace pointed to (bottom 25% of its family); net income of $391 million against a prior three-year average of $210 million (bottom 15%); a net margin of -6.6% against -4.9% before (bottom 5%) (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made